Svati H. Shah, MD, MS, MHS is the Ursula Geller Distinguished Professor of Medicine, Professor of Biostatistics and Bioinformatics and a physician scientist at Duke University. She is the Associate Dean of Genomics, Director of the Duke Center for Precision Health, Director of the Precision Genomics Collaboratory, Vice-Chief of Translational Research in the Division of Cardiology, Department of Medicine, a faculty member and Co-Director of Translational Research in the Duke Molecular Physiology Institute (DMPI) and a faculty member of the Duke Clinical Research Institute (DCRI). Her NIH-funded translational laboratory within the DMPI focuses on the study of metabolic and genetic pathways and biomarkers in cardiometabolic diseases, using large cardiovascular cohorts to perform discovery studies with genetics, metabolomics and proteomics and subsequent functional validation for mechanistic insight. Dr. Shah’s seminal work has resulted in the identification of novel CAD genes; metabolic biomarkers that predict CVD events; and novel pathways of CVD pathogenesis including the branched chain amino acid (BCAA) pathway.  She has published >260 manuscripts and she is a member of the American Society of Clinical Investigation (ASCI), Association of American Physicians (AAP) and the Association of University Cardiologists (AUC). Dr. Shah is also a practicing cardiologist and echocardiographer, and is Director of the Duke Adult Cardiovascular Genetics Clinic where she cares for patients and families with cardiovascular genetic disorders. Dr. Shah is actively involved with service to the NIH, including having served as a standing member and ad hoc on study sections, her current role as Co-Chair of the NHLBI’s HeartShare program, and serving on the steering committee of the NCI COMETS Consortium and co-chairing the COMETS CVD Working Group; and she is involved with the American Heart Association, currently serving as the Chair of the AHA’s Research Committee, National Board of Directors Member, Associate Editor for Circulation, and former Chair of the Council for Genomic and Precision Medicine.